[go: up one dir, main page]

MA39188A1 - Peptidomimetic compounds and antibody-drug conjugates thereof - Google Patents

Peptidomimetic compounds and antibody-drug conjugates thereof

Info

Publication number
MA39188A1
MA39188A1 MA39188A MA39188A MA39188A1 MA 39188 A1 MA39188 A1 MA 39188A1 MA 39188 A MA39188 A MA 39188A MA 39188 A MA39188 A MA 39188A MA 39188 A1 MA39188 A1 MA 39188A1
Authority
MA
Morocco
Prior art keywords
antibody
drug conjugates
peptidomimetic compounds
peptidomimetic
compounds
Prior art date
Application number
MA39188A
Other languages
French (fr)
Inventor
Binqing Wei
John A Flygare
Brian Safina
Leanna Staben
Thomas H Pillow
Moana Tercel
Ho Huat Lee
Janet Gunzner-Toste
Vishal Verma
Guiling Zhao
Original Assignee
Genentech Inc
Moana Tercel
The Univ Of Auckland
Ho Huat Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Moana Tercel, The Univ Of Auckland, Ho Huat Lee filed Critical Genentech Inc
Priority claimed from PCT/US2014/070660 external-priority patent/WO2015095227A2/en
Publication of MA39188A1 publication Critical patent/MA39188A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des éléments de liaison peptidomimétiques et des conjugués anticorps-médicaments de ceux-ci, des compositions pharmaceutiques les contenant, et leur utilisation dans la thérapie pour la prévention ou le traitement du cancer.The invention relates to peptidomimetic binding members and antibody-drug conjugates thereof, pharmaceutical compositions containing them, and their use in therapy for the prevention or treatment of cancer.

MA39188A 2013-12-16 2014-12-16 Peptidomimetic compounds and antibody-drug conjugates thereof MA39188A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361916661P 2013-12-16 2013-12-16
PCT/US2014/070660 WO2015095227A2 (en) 2013-12-16 2014-12-16 Peptidomimetic compounds and antibody-drug conjugates thereof

Publications (1)

Publication Number Publication Date
MA39188A1 true MA39188A1 (en) 2018-05-31

Family

ID=58698563

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39188A MA39188A1 (en) 2013-12-16 2014-12-16 Peptidomimetic compounds and antibody-drug conjugates thereof

Country Status (2)

Country Link
AR (1) AR098781A1 (en)
MA (1) MA39188A1 (en)

Also Published As

Publication number Publication date
AR098781A1 (en) 2016-06-15

Similar Documents

Publication Publication Date Title
EA201691059A1 (en) PEPTIDOMYMETICS COMPOUNDS AND THEIR CONJUGATES CONTAINING ANTIBODY AND MEDICINE
MX2025009223A (en) Clec9a binding agents and use thereof
PH12020500500A1 (en) Pyrazolopyrimidinone compounds and uses thereof
PH12016501171A1 (en) Peptidomimetic compounds and antibody-drug conjugates thereof
EA201790674A1 (en) CYTOTOXIC INDUCING THERAPEUTIC AGENT
MA47313B1 (en) Her2 antibody subcutaneous formulations
PH12015500825B1 (en) Substituted benzene compounds
MA38396A1 (en) Conjugated drug antibodies and their pharmaceutical compositions for treating a ckit positive cancer
PH12016500575A1 (en) Inhibitors of bruton`s tyrosine kinase
EA201590855A1 (en) COMPOUNDS OF PYRROPOLYMIDININE AS KINAZ INHIBITORS
EP2818483A4 (en) MEDICINAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
UA112434C2 (en) ANTIGENCY BINDING SPECIFICALLY Binds to ALL
EP2818482A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
EP2818481A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
EP2824114A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
MX375752B (en) BRUTON'S TYROSINE KINASE INHIBITORS.
EA201690159A1 (en) METHODS AND COMPOSITIONS FOR CANCER TREATMENT
MA38253B1 (en) Compositions comprising vortioxetine and donepezil
MA38190A2 (en) Autotaxin inhibitors
EP3362096A4 (en) OPHTHALMIC TREATMENT COMPOSITION AND VEHICLE FOR THE ADMINISTRATION OF PHARMACEUTICAL SUBSTANCES OR THERAPEUTIC AGENTS
EP2857007A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING VERBENONE DERIVATIVE FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISEASE
EP2962693A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF CANCER
MA39447B1 (en) Pirlindole or its pharmaceutically acceptable salts for use in medicine
EP2963125A4 (en) METHOD FOR MICRO-RNA ANALYSIS, ANTICANCER THERAPEUTIC AGENT, AND MEDICINAL COMPOSITION CONTAINING THE SAME FOR ANTICANCER THERAPY
MA39448B1 (en) (r) -pirlindole and its pharmaceutically acceptable salts for medical use